Image

Evaluation of Long-Acting Lenacapavir for the Treatment of HIV-1 in Treatment-experienced Adolescents and Children

Studying a new HIV treatment for kids and teens.

Recruiting
17 years and younger
All
Phase 2
  • Simplified description (AI rewritten)
  • Technical description (Original)

This study is looking at how well a new drug, lenacapavir (LEN), works for treating HIV-1 in kids and teens. HIV-1 is a virus that attacks the immune system. The study wants to see if LEN is safe and if it works when used with other HIV medicines. It will also check if it's easy for kids to take as a shot or pill.

Key Points:

  • The study is for kids and teens who weigh at least 35 kg and have tried other HIV treatments before.
  • Participants need to keep taking their current HIV meds until the study starts.
  • Participants must be willing to take LEN along with their other medicines.

To join, kids need to be healthy enough, with some specific lab test results, and not have certain other health issues. The study will help doctors know if LEN is a good option for treating HIV-1 in young people.

Print
Study details
    HIV-1-infection

NCT06749054

Gilead Sciences

28 June 2025

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Race
Ethnicity
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.